AlphaCentric Advisors’s CVS Health CVS Stock Holding History

AlphaCentric Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Buy	1,705 +90	+6%	+$8.03K	0.15%	174
2026 Q1	$116K	Buy	1,615 +65	+4%	+$5.01K	0.12%	204
2025 Q4	$123K	Buy	+1,550	New	+$122K	0.12%	201
2023 Q2	–	Sell	-1,281	Closed	-$95.2K	–	241
2023 Q1	$95.2K	Sell	1,281 -56	-4%	-$4.7K	0.07%	188
2022 Q4	$125K	Sell	1,337 -1,370	-51%	-$132K	0.12%	141
2022 Q3	$258K	Buy	+2,707	New	+$268K	0.26%	83
2021 Q4	$93K	Buy	+897	New	+$82.9K	0.03%	157
2021 Q2	–	Sell	-2,948	Closed	-$222K	–	219
2021 Q1	$222K	Sell	2,948 -79	-3%	-$5.75K	0.07%	87
2020 Q4	$207K	Sell	3,027 -211	-7%	-$13.7K	0.09%	66
2020 Q3	$189K	Sell	3,238 -231	-7%	-$14.4K	0.09%	46
2020 Q2	$225K	Buy	+3,469	New	+$218K	0.13%	40

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AlphaCentric Advisors's CVS Position: Q2 2026 in Review

AlphaCentric Advisors increased its CVS Health (CVS) stake by 5.6% in Q2 2026, buying an estimated $8.03K and bringing the position to 1,705 shares worth $176K. The position accounts for 0.15% of the portfolio, ranked #174.

AlphaCentric Advisors first reported a position in CVS in Q2 2020 and has held it in 11 quarters since. The position peaked at $258K in Q3 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

AlphaCentric Advisors held 1,705 shares of CVS Health worth $176K as of Q2 2026.
AlphaCentric Advisors bought 90 CVS Health shares in Q2 2026, an estimated $8.03K.
CVS Health made up 0.15% of AlphaCentric Advisors's portfolio in Q2 2026, its #174 holding.
AlphaCentric Advisors first reported a position in CVS Health in Q2 2020 and has held it in 11 quarters since.
AlphaCentric Advisors's CVS Health position peaked at $258K in Q3 2022.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.